764 Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study

@article{Kowdley2014764SW,
  title={764 Sofosbuvir/Ledipasvir With and Without Ribavirin for 8 Weeks Compared to Sofosbuvir/Ledipasvir for 12 Weeks in Treatment-Naive Non-Cirrhotic Genotype-1 HCV-Infected Patients: The Phase 3 Ion-3 Study},
  author={Kris V. Kowdley and Stuart C. Gordon and Karunanidhi. Reddy and Lorenzo Rossaro and David Bernstein and Di An and Evguenia S. Svarovskaia and Rob H. Hyland and Phil S Pang and William T. Symonds and John McHutchison and Andrew J. Muir and Paul J. Pockros and David S. Pound and Michael W. Fried},
  journal={Gastroenterology},
  year={2014},
  volume={146}
}

Topics from this paper.

Similar Papers

Loading similar papers…